Hyper Pigmentation Global Clinical Trials Review, H1, 2014
Summary
GlobalData's clinical trial report, Hyper Pigmentation Global Clinical Trials Review, H1, 2014" provides data on the Hyper Pigmentation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyper Pigmentation. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyper Pigmentation. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Browse Complete report with TOC :
http://www.marketresearchreports.biz/analysis-details/hyper-pigmentation-global-clinical-trials-review-h1-2014
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
To Download Sample Report Visit @
http://www.marketresearchreports.biz/sample/sample/188577
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hyper Pigmentation 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Hyper Pigmentation to Dermatology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Hyper Pigmentation to Dermatology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Hyper Pigmentation Therapeutics Clinical Trials 26
Prominent Drugs 27
Latest Clinical Trials News on Hyper Pigmentation 28
Jul 12, 2011: Azelaic Acid Gel Improves Post-Inflammatory Hyperpigmentation In Acne Patients With Dark Skin Types 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Kasiak Research Pvt. Ltd. 29
Clinical Trial Overview of Kasiak Research Pvt. Ltd. 29
Johnson & Johnson 30
Clinical Trial Overview of Johnson & Johnson 30
Bayer AG 31
Visit Analysis Report @
http://www.marketresearchreports.biz/analysis/188577
Clinical Trial Overview of Bayer AG 31
Sante Mernaud Pharmaceuticals Pvt. Ltd. 32
Clinical Trial Overview of Sante Mernaud Pharmaceuticals Pvt. Ltd. 32
nPharmakon 33
Clinical Trial Overview of nPharmakon 33
Glenmark Pharmaceuticals Ltd. 34
Clinical Trial Overview of Glenmark Pharmaceuticals Ltd. 34
Galderma S.A. 35
Clinical Trial Overview of Galderma S.A. 35
Clinical Trial Overview of Top Institutes / Government 36
The Indian Association of Dermatologists, Venereologists and Leprologists 36
Clinical Trial Overview of The Indian Association of Dermatologists, Venereologists and Leprologists 36
Tabriz University of Medical Sciences 37
Clinical Trial Overview of Tabriz University of Medical Sciences 37
Callender Center for Clinical Research 38
Clinical Trial Overview of Callender Center for Clinical Research 38
Tohoku University Graduate School of Medicine, Department Of Surgery 39
Clinical Trial Overview of Tohoku University Graduate School of Medicine, Department Of Surgery 39
Brazilian Center for Studies in Dermatology 40
Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz
meet us on:
facebook: http://facebook.com/marketresearchreports.biz
twitter: http://twitter.com/mrrbizreport/
Summary
GlobalData's clinical trial report, Hyper Pigmentation Global Clinical Trials Review, H1, 2014" provides data on the Hyper Pigmentation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyper Pigmentation. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyper Pigmentation. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Browse Complete report with TOC :
http://www.marketresearchreports.biz/analysis-details/hyper-pigmentation-global-clinical-trials-review-h1-2014
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
To Download Sample Report Visit @
http://www.marketresearchreports.biz/sample/sample/188577
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hyper Pigmentation 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Hyper Pigmentation to Dermatology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Hyper Pigmentation to Dermatology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Hyper Pigmentation Therapeutics Clinical Trials 26
Prominent Drugs 27
Latest Clinical Trials News on Hyper Pigmentation 28
Jul 12, 2011: Azelaic Acid Gel Improves Post-Inflammatory Hyperpigmentation In Acne Patients With Dark Skin Types 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Kasiak Research Pvt. Ltd. 29
Clinical Trial Overview of Kasiak Research Pvt. Ltd. 29
Johnson & Johnson 30
Clinical Trial Overview of Johnson & Johnson 30
Bayer AG 31
Visit Analysis Report @
http://www.marketresearchreports.biz/analysis/188577
Clinical Trial Overview of Bayer AG 31
Sante Mernaud Pharmaceuticals Pvt. Ltd. 32
Clinical Trial Overview of Sante Mernaud Pharmaceuticals Pvt. Ltd. 32
nPharmakon 33
Clinical Trial Overview of nPharmakon 33
Glenmark Pharmaceuticals Ltd. 34
Clinical Trial Overview of Glenmark Pharmaceuticals Ltd. 34
Galderma S.A. 35
Clinical Trial Overview of Galderma S.A. 35
Clinical Trial Overview of Top Institutes / Government 36
The Indian Association of Dermatologists, Venereologists and Leprologists 36
Clinical Trial Overview of The Indian Association of Dermatologists, Venereologists and Leprologists 36
Tabriz University of Medical Sciences 37
Clinical Trial Overview of Tabriz University of Medical Sciences 37
Callender Center for Clinical Research 38
Clinical Trial Overview of Callender Center for Clinical Research 38
Tohoku University Graduate School of Medicine, Department Of Surgery 39
Clinical Trial Overview of Tohoku University Graduate School of Medicine, Department Of Surgery 39
Brazilian Center for Studies in Dermatology 40
Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz
meet us on:
facebook: http://facebook.com/marketresearchreports.biz
twitter: http://twitter.com/mrrbizreport/
No comments:
Post a Comment